65F ACS VT S/P DCCV SAH SDH
Diagnosis :
CAD: Effort Angina
TMT - Positive
S/P CAG - SVD
S/P PTCA stent to LAD
VT Episode
-- DCCV -->
NSR
S/P Mechanical ventilation (Extubated on 26.10.26)
Diffuse SAH / SDH
Past Medical History
:
Non obstructive HCM
Chief Complaints :
Mrs. xxxxx, aged 65 years old female, known case of non
obstructive HCM, TMT - Positive, S/P Adhoc
PTCA to LAD with 2 DES [24.10.26], 2
VT episodes during angioplasty (150 - 200 J DC shock delivered) --> Sinus
rhythm, she was intubated and put on mechanical ventilation and started on
Vasopressors / anti arrhytmias, Post procedure CT Brain done showed diffuse SAH
parieto occipital region with minimal SAH in Rt. frontal. Thin SDH measuring
2-3mm along with paramedian infarct anteriorly and posteriorly, CT KUB : B/L
Small kidneys with cortical scars, MRI Brain and Venogram done, no
active surgical intervention, she was referred back to DDH.
General
Examination :
Patient Conscious / Coherent :
No Pallor , No Icterus
, No Clubbing , No Edema , No Cynosis
:
Pulse Rate : 80 / Min
Temperature : 98.4
Blood Pressure : 100/70 mmHg
Respiratory Rate : 20 / Min
Saturation : On Mechanical ventilator support
Systemic
Examination
CVS [ S1 , S2 PRESENT
] , Resp. System [ BAE +, B/L Crepts+
] , Abdomen [ SOFT,
BS + ] , CNS [
NAD, GCS, 15 / 15 ]
Course In the Hospital :
Mrs. xxxx, aged 65 years
old female, got admitted with the above
mentioned complaints to the
hospital. She was treated with IV antiepileptic, antibiotics, antiplatelets,
statins and other supportive medications. Routine investigations done. Patient
had 2 episodes of VT, S/P DCCV - NSR. In view of low GCS, Neurophysician
consultation done and diagnosed as Mild SAH with SDH (No neurological deficits)
and treated accordingly. In view of elevated SGOT& SGPT, Medical
Gastroenterologist consultation done and advice followed. Repeat CT Brain
showed Resolving SAH and SDH, No mass effect, Neurophysician review done and
advice followed. In view of non obstructive HCM, H/o Hematuria, Urologist
consultation done and treated accordingly. In view of HB - 7.7 gm/dl, 1 unit of
PRBC was transfused. Patient was stable at the time of discharge. She was discharged on the following medications and
advises. Long term prognosis was explained in detail.
Investigations : Cummulative Report
|
Date |
29-10- 2026 10:30 |
28-10- 2026 09:52 |
27-10- 2026 10:37 |
|
|
Units |
Reference |
|
Haemoglobin |
11.7 |
12.0 |
7.7* |
|
|
g% |
11 - 16 |
|
RBC Count |
3.9* |
4.0 |
2.5* |
|
|
x10^6/ul |
4 - 5.2 |
|
Total WBC Count |
8400 |
11300* |
13300* |
|
|
cells/cumm |
4000 - 11000 |
|
Platelet Count |
1.58 |
1.45* |
1.42* |
|
|
Lakhs/cum m |
1.5 - 4.5 |
|
Packed Cell
Volume (PCV) |
34.3* |
35.0* |
22.5* |
|
|
% |
36 - 46 |
|
Mean
Corpuscular Haemoglobin (MCV) |
86.8 |
86.7 |
87.8 |
|
|
fl |
70 - 100 |
|
Mean
Corpuscular Heamoglobin(MCH) |
29.6 |
29.8 |
29.9 |
|
|
pg |
27 - 32 |
|
MeanCorpuscular Heamoglobin Concetration(MCHC) |
34.1 |
34.3 |
34.0 |
|
|
g/dl |
32 - 36 |
|
RDW |
13.4 |
13.7 |
14.0 |
|
|
% |
11.6 - 14 |
|
Granulocytes |
80* |
85* |
90* |
|
|
% |
40 - 75 |
|
Lymphocytes |
15* |
10* |
05* |
|
|
% |
20 - 40 |
|
Eosinophils |
03 |
03 |
03 |
|
|
% |
0 - 6 |
|
Monocytes |
02 |
02 |
02 |
|
|
% |
2 - 10 |
|
Basophils |
00 |
00 |
00 |
|
|
% |
0 - 1 |
|
Date |
28-10- 2026 09:52 |
27-10- 2026 10:37 |
26-10- 2026 19:55 |
26-10- 2026 16:56 |
24-10- 2026 17:00 |
Units |
Reference |
|
Sodium |
139 |
150* |
149* |
147* |
144 |
mmol/L |
135 - 145 |
|
Potassium |
3.5 |
3.9 |
4.6 |
4.1 |
3.0* |
mmol/L |
3.5 - 5.1 |
|
Calcium |
1.21 |
1.30 |
1.14 |
1.20 |
1.08* |
mmol/L |
1.13 - 1.32 |
|
Creatinine |
0.80 |
1.0 |
1.7* |
1.5* |
0.90 |
mg/dl |
0.6 - 1.2 |
|
Blood Urea |
53* |
68* |
60* |
95* |
29 |
mg/dl |
10 - 45 |
|
Egfr |
33 |
|
|
|
|
ml/min/1.73 m2 |
|
|
Date |
27-10- 2026 10:37 |
24-10- 2026 17:00 |
|
|
|
Units |
Reference |
|
Total Bilirubin |
0.70 |
0.33 |
|
|
|
mg/dl |
0.3 - 1.2 |
|
Direct Bilirubin |
0.30 |
0.15 |
|
|
|
mg/dl |
0 - 0.4 |
|
SGOT |
442* |
120* |
|
|
|
U/L |
0 - 31 |
|
SGPT |
115* |
95* |
|
|
|
U/L |
0 - 35 |
|
Alkaline Phosphatase |
118 |
111 |
|
|
|
U/L |
108 - 306 |
|
Total Protein |
4.9* |
6.3 |
|
|
|
g/dl |
6 - 8 |
|
Albumin |
2.5* |
3.5 |
|
|
|
g/dl |
3.5 - 5.2 |
|
Globulin |
2.4* |
2.8 |
|
|
|
g/dl |
2.5 - 3.5 |
|
A:G Ratio |
1.04 |
1.25 |
|
|
|
% |
1 - 2.1 |
|
Date |
27-10- 2026 |
26-10- 2026 |
24-10- 2026 |
|
|
Units |
Reference |
|
|
10:37 |
19:57 |
20:05 |
|
|
|
|
|
Test |
20.1* |
19.0* |
20.0* |
|
|
Seconds |
13 - 17 |
|
Control |
12.0 |
12.0 |
12.0 |
|
|
Seconds |
|
|
INR |
1.7 |
1.6 |
1.7 |
|
|
- |
|
Discharge Medication
|
Order
Date |
Drug Name |
Dose |
Route |
Frequency |
Duration |
Remark |
|
29-10-2026 01:48
PM |
TAB ECOSPRIN 75MG |
75 mg |
ORAL |
Once Daily(OD) |
daily |
2PM AFTER
FOOD |
|
29-10-2026 01:48
PM |
TAB BRONAC
600 MG |
600 mg |
ORAL |
BD(TWICE DAILY) |
daily |
8AM - 8PM
AFTER FOOD |
|
29-10-2026 01:48
PM |
TAB PAN
40MG |
40 mg |
ORAL |
Once Daily(OD) |
daily |
7AM BEFORE
BREAKFAST |
|
29-10-2026 01:48
PM |
TAB ALDACTONE 25MG |
25 mg |
ORAL |
Once Daily(OD) |
daily |
2PM AFTER
FOOD |
|
29-10-2026 01:48
PM |
TAB NIKORAN 5 MG |
5 mg |
ORAL |
BD(TWICE DAILY) |
daily |
8AM - 8PM
AFTER FOOD |
|
29-10-2026 01:48
PM |
TAB NODOSIS |
1 gm |
ORAL |
TID(THRICE DAILY) |
daily |
8AM - 2PM - 8PM AFTER FOOD |
|
29-10-2026 01:48
PM |
TAB CLOPITAB 75MG |
75 mg |
ORAL |
Once Daily(OD) |
daily |
2PM AFTER
FOOD |
|
29-10-2026 01:48
PM |
TAB LEVIPIL 500MG |
500 mg |
ORAL |
BD(TWICE DAILY) |
daily |
8AM - 8PM
AFTER FOOD |
Condition at Discharge :
Patient Conscious / Coherent
No Pallor
, No Icterus , No Clubbing , No Edema
, No Cynosis
Pulse Rate : 80 / Min
Temperature : 98.4
Blood Pressure
: 100/70 mmHg
Respiratory Rate : 20 / Min
Saturation : 98 % On Room Air
Comments
Post a Comment